Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This emerging Bitcoin infrastructure company is building a vertically integrated model (click to learn more) Laser Photonics Announces Strategic Milestone on Advanced Laser Shield Anti Drone System (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Healthcare Biotechnology
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. The company’s lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein cholesterol, recent acute coronary... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:RVX)

Resverlogix Corp. Announces Issuance of MCTO by ASC

Newsfile 13 days ago

Resverlogix Corp. Provides Bi-Weekly MCTO Status Update

Newsfile March 31, 2026

Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A

Newsfile March 17, 2026

Resverlogix Closes $2.8 Million Shares-for-Interest Private Placement

Newsfile February 18, 2026

Resverlogix Appoints Bradley Glass to Board of Directors

Newsfile November 18, 2025

Resverlogix Announces Voting Results from the 2025 Meeting of Shareholders

Newsfile June 30, 2025

Numerous Independent Groups Presented Data that Supports Apabetalone's Potential Cardioprotective Benefits at European Society of Cardiology Congress 2024

Newsfile September 3, 2024

Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension

Newsfile July 31, 2024

Resverlogix Provides Update Regarding Two-Year Extension of Debenture and Elimination of Conversion Privileges

Newsfile July 16, 2024
View More News ››

Opinion & Analysis (TSX:RVX)

Buzz on the Bullboards: Will Cooler Heads Prevail?

Omri Wallach October 3, 2019

'Pivotal Topline Up Next' for Biotech's Phase 3 Cardiac Clinical Trial

Streetwise Reports May 2, 2019

Biotech’s Lead Drug Candidate Targets 'Market with Huge Potential'

Streetwise Reports November 2, 2018

Biotech's shares 'undervalued' and positioned for 'long-term upside potential'

Streetwise Reports December 28, 2017

Biotech receives 'major endorsement from world-leading pharma company'

Streetwise Reports December 21, 2017

Coverage initiated on 'one of the most undervalued biotech companies in Canada'

Streetwise Reports December 8, 2017
View More Opinion ››

Bullboard Posts (TSX:RVX)

Re that large bid

I thought it was a head fake by someone actually trying to get the sp up and the person was actually going to sell .Nice try but the sp...
Storm23 - March 21, 2026

FDA and Canada sentiment

Would the FDA drag their heels on a Canadian biotech drug going thru trials due to the anti Canada bias?
Storm23 - February 26, 2026

Is Brad Cann

Going to be the new CEO ?Cant see Don holding the job much longer .
Storm23 - February 23, 2026

Zen AGM

Looks like another live webcast ,and a few people at the office .Not in person at Mount Royal as it used to be .No accountability from...
Storm23 - February 7, 2026

Bradley Glass

coming on board,is it good news or bad?Could go either way at this point.Need clarity ,need ZEN AGM,need some action.
Storm23 - January 18, 2026

What is Resverlogix???

Resverlogix Corp. is a Canada-based late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic...
narmac - January 18, 2026
View more Bullboard ››

Kobrea Exploration Corp.

Kobrea Exploration Corp.

Kobrea Exploration Corp. engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It holds a ...
View More »

Podcasts